Varicelle
Preventing varicella: Recommendations for routine two-dose varicella immunization in children
This statement presents the rationale for a two-dose immunization strategy in Canada, as well as recommendations for a routine two-dose varicella vaccine schedule for all Canadian children. Children who have had one dose of varicella vaccine and have not had breakthrough infection should receive another dose of varicella vaccine. This document replaces the Canadian Paediatric Society's 2005 position statement on varicella prevention.
Update on Measles-Mumps-Rubella-Varicella Vaccine and Febrile Seizures: An Advisory Committee Statement (ACS)
Highlights key information for immunization providers.
Updated recommendations for the use of varicella zoster immune globulin (VarIg) for the prevention of varicella in at-risk patients: An Advisory Committee Statement (ACS)
Highlights key information for immunization providers. VarIg is recommended for individuals who are at increased risk of severe varicella if significant exposure has occurred. These individuals include: susceptible pregnant women; newborn infants of mothers who develop varicella from 5 days before until 48 hours after delivery; selected neonates in neonatal or pediatric intensive-care settings; susceptible immunocompromised individuals, including susceptible HIV-infected persons and hematopoietic stem cell transplantation recipients.
Vaccine coverage in Canadian children: Highlights from the 2013 childhood National Immunization Coverage Survey (cNICS)
The 2013 Childhood National Immunization Coverage Survey (cNICS) is the largest national-level immunization coverage survey ever carried out in Canada. Results from the survey showed that the majority of Canadian children are immunized against vaccine-preventable diseases, but there is room to improve in keeping vaccinations up to date.
Vaccine uptake in Canadian adults: results from the 2014 adult National Immunization Coverage Survey
The Adult National Immunization Coverage Survey (aNICS) constitutes an ongoing approach to measuring adult immunization coverage in Canada and monitoring progress towards national targets. The next aNICS cycle will take place in 2016. The Public Health Agency of Canada will continue to work to collaborate with provinces, territories and other stakeholders to improve immunization coverage assessment methodology. Public and professional education and outreach campaigns will also continue to promote the benefits and safety of immunization in Canada.
Varicella Proof of Immunity - 2015 Update: An Advisory Committee Statement (ACS)
The National Advisory Committee on Immunization (NACI) currently recommends a 2-dose varicella vaccination schedule for all children aged 12 months to 12 years of age. Susceptible adolescents (12 to 17 years) and adults (18 years and older) should also be vaccinated. The Canadian Immunization Guideenumerates criteria for proof of immunity.
Couverture vaccinale des adultes au Canada : Résultats de l'Enquête nationale sur la vaccination des adultes (ENVA) de 2012
Depuis 2001, l'Agence de la santé publique du Canada (l'Agence) évalue régulièrement le taux de couverture vaccinale des adultes à l'échelle nationale pour certains vaccins au moyen de l'Enquête nationale sur la vaccination des adultes (ENVA). Les résultats de ces enquêtes sont utilisés pour évaluer les progrès réalisés en vue d'atteindre les cibles de couverture vaccinale à l'échelle nationale, rendre compte des données estimatives de couverture vaccinale aux organismes internationaux, améliorer la planification de la préparation en cas de pandémie de grippe et mettre au point des stratégies ciblées et pertinentes de sensibilisation du public.
Unprotected people reports
Includes case reports, personal testimonies, newspaper and journal articles about people who have suffered or died from vaccine-preventable diseases.
Vaccine coverage amongst adult Canadians: Results from the 2012 adult National Immunization Coverage (aNIC) survey
Since 2001, the Public Health Agency of Canada (the Agency) routinely monitors national immunization coverage for select adult immunizations through the adult National Immunization Coverage Survey (aNICS). Results from these surveys are used to monitor progress towards national targets for immunization coverage, to report immunization coverage estimates to international organizations, to improve planning for pandemic influenza and to develop appropriately targeted public education strategies.
La varicelle
Offre de l’information sur la varicelle, les causes, les risques, les symptômes, la prévention, le traitement, la surveillance, et des informations spécifiques à l’intention des professionnels de la santé.